

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 7.76342002 |
| 2 | regulation of protein activation cascade (GO:2000257) | 7.66204693 |
| 3 | regulation of fibrinolysis (GO:0051917) | 7.56069591 |
| 4 | regulation of complement activation (GO:0030449) | 7.36669599 |
| 5 | complement activation, alternative pathway (GO:0006957) | 7.08535970 |
| 6 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.63901300 |
| 7 | protein carboxylation (GO:0018214) | 6.63901300 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 6.39761906 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.39761906 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 6.01467396 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.01467396 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 5.88471168 |
| 13 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.73077736 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.71165431 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 5.60883997 |
| 16 | plasma lipoprotein particle assembly (GO:0034377) | 5.51261361 |
| 17 | protein-lipid complex remodeling (GO:0034368) | 5.42022118 |
| 18 | macromolecular complex remodeling (GO:0034367) | 5.42022118 |
| 19 | plasma lipoprotein particle remodeling (GO:0034369) | 5.42022118 |
| 20 | fibrinolysis (GO:0042730) | 5.39166658 |
| 21 | cholesterol efflux (GO:0033344) | 5.35371650 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 5.34687690 |
| 23 | negative regulation of sterol transport (GO:0032372) | 5.34687690 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.32651613 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.28009155 |
| 26 | phospholipid efflux (GO:0033700) | 5.27189145 |
| 27 | drug catabolic process (GO:0042737) | 5.21017988 |
| 28 | regulation of plasminogen activation (GO:0010755) | 5.12289769 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 5.10157263 |
| 30 | glyoxylate metabolic process (GO:0046487) | 5.08915197 |
| 31 | exogenous drug catabolic process (GO:0042738) | 5.08431039 |
| 32 | urea metabolic process (GO:0019627) | 4.98701930 |
| 33 | ethanol oxidation (GO:0006069) | 4.97869055 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 4.92131100 |
| 35 | protein-lipid complex assembly (GO:0065005) | 4.89317429 |
| 36 | protein activation cascade (GO:0072376) | 4.81520470 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.78964168 |
| 38 | omega-hydroxylase P450 pathway (GO:0097267) | 4.71558950 |
| 39 | regulation of humoral immune response (GO:0002920) | 4.69868565 |
| 40 | * acute-phase response (GO:0006953) | 4.65452332 |
| 41 | intestinal cholesterol absorption (GO:0030299) | 4.62411435 |
| 42 | plasma lipoprotein particle organization (GO:0071827) | 4.61149629 |
| 43 | complement activation, classical pathway (GO:0006958) | 4.60334171 |
| 44 | regulation of apoptotic cell clearance (GO:2000425) | 4.52447954 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.50608669 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.50608669 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.48494528 |
| 48 | cellular glucuronidation (GO:0052695) | 4.47883221 |
| 49 | urea cycle (GO:0000050) | 4.47605790 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.44187784 |
| 51 | complement activation (GO:0006956) | 4.42688029 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.40130030 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.37183601 |
| 54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.37183601 |
| 55 | protein-lipid complex subunit organization (GO:0071825) | 4.32823347 |
| 56 | regulation of bile acid biosynthetic process (GO:0070857) | 4.32652104 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 4.30689106 |
| 58 | glucuronate metabolic process (GO:0019585) | 4.30305256 |
| 59 | uronic acid metabolic process (GO:0006063) | 4.30305256 |
| 60 | negative regulation of complement activation (GO:0045916) | 4.29127665 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.24732464 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.24732464 |
| 63 | positive regulation of hemostasis (GO:1900048) | 4.19286278 |
| 64 | positive regulation of blood coagulation (GO:0030194) | 4.19286278 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.18512113 |
| 66 | negative regulation of coagulation (GO:0050819) | 4.16636567 |
| 67 | drug metabolic process (GO:0017144) | 4.10364588 |
| 68 | bile acid metabolic process (GO:0008206) | 4.05024678 |
| 69 | ethanol metabolic process (GO:0006067) | 4.02416449 |
| 70 | negative regulation of wound healing (GO:0061045) | 4.01794206 |
| 71 | negative regulation of lipase activity (GO:0060192) | 4.00411080 |
| 72 | bile acid biosynthetic process (GO:0006699) | 3.89411344 |
| 73 | positive regulation of coagulation (GO:0050820) | 3.89115938 |
| 74 | phenylpropanoid metabolic process (GO:0009698) | 3.81524838 |
| 75 | glutamate metabolic process (GO:0006536) | 3.71436110 |
| 76 | * acute inflammatory response (GO:0002526) | 3.60096705 |
| 77 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.60081955 |
| 78 | lipoprotein metabolic process (GO:0042157) | 3.59606240 |
| 79 | cytolysis (GO:0019835) | 3.57756741 |
| 80 | cholesterol homeostasis (GO:0042632) | 3.57281246 |
| 81 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.56692508 |
| 82 | bile acid and bile salt transport (GO:0015721) | 3.54842808 |
| 83 | negative regulation of humoral immune response (GO:0002921) | 3.53285073 |
| 84 | sterol homeostasis (GO:0055092) | 3.51629680 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.47696140 |
| 86 | intestinal absorption (GO:0050892) | 3.41365044 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39633379 |
| 88 | cholesterol transport (GO:0030301) | 3.37410819 |
| 89 | sterol transport (GO:0015918) | 3.37410819 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.37179533 |
| 91 | diacylglycerol metabolic process (GO:0046339) | 3.36786885 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.31832645 |
| 93 | oxidative demethylation (GO:0070989) | 3.31694060 |
| 94 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.28580524 |
| 95 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.28580524 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.25636316 |
| 97 | tyrosine metabolic process (GO:0006570) | 3.25381688 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.25364394 |
| 99 | opsonization (GO:0008228) | 3.24988494 |
| 100 | regulation of acute inflammatory response (GO:0002673) | 3.24512440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.73997378 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06747019 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.17568267 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.10390918 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.96124666 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.10926492 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.97919704 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63731109 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41777415 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25260252 |
| 11 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.96508997 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.57757598 |
| 13 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.41659653 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38559024 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.30755509 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91034116 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87395591 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.67743608 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67495882 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57347388 |
| 21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56295441 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.56076905 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.43635428 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32664573 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28731206 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28266014 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26234035 |
| 28 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25871986 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22182369 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21383447 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20896124 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19149273 |
| 33 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.18282919 |
| 34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15559346 |
| 35 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.15521737 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14823831 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13950713 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13379263 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13005798 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10958489 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10457475 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03589499 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02949918 |
| 44 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02175773 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99563721 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96249624 |
| 47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91897329 |
| 48 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91803244 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88178674 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87672941 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86615811 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86562131 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86371068 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84260387 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83333607 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81166644 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81132906 |
| 58 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80255003 |
| 59 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75945129 |
| 60 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75569997 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73471567 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73439967 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73317207 |
| 64 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70541980 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69406846 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69289218 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69271125 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.69097045 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69047979 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68828107 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68715160 |
| 72 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68401673 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67378878 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66801926 |
| 75 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.66481573 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66382566 |
| 77 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65978290 |
| 78 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65575057 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.64482386 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64419158 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.63854071 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63589874 |
| 83 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.63211363 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.62562742 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 0.62105244 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.61809122 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.60393538 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60315767 |
| 89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60308981 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59671345 |
| 91 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.59541648 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58763297 |
| 93 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58586783 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57689689 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.57610682 |
| 96 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.57422483 |
| 97 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.57329334 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.57307632 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57252768 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.57061246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15791199 |
| 2 | MP0005360_urolithiasis | 6.27185481 |
| 3 | MP0005365_abnormal_bile_salt | 5.65958832 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.35971871 |
| 5 | MP0003195_calcinosis | 4.66233097 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.92405441 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.67795156 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.40416103 |
| 9 | MP0003252_abnormal_bile_duct | 3.31861992 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.31778614 |
| 11 | MP0009840_abnormal_foam_cell | 3.01228419 |
| 12 | MP0003868_abnormal_feces_composition | 2.81007386 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.40930564 |
| 14 | MP0005332_abnormal_amino_acid | 2.15658301 |
| 15 | MP0000609_abnormal_liver_physiology | 1.92134092 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.91662150 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.87667743 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.84898120 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.80800852 |
| 20 | MP0005451_abnormal_body_composition | 1.79203433 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.57669792 |
| 22 | MP0002132_abnormal_respiratory_system | 1.57649841 |
| 23 | MP0003122_maternal_imprinting | 1.54761970 |
| 24 | MP0001764_abnormal_homeostasis | 1.45949630 |
| 25 | MP0005408_hypopigmentation | 1.41578437 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.37737828 |
| 27 | MP0003436_decreased_susceptibility_to | 1.35392870 |
| 28 | MP0000604_amyloidosis | 1.33618986 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.25614974 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.25035468 |
| 31 | MP0009697_abnormal_copulation | 1.22242600 |
| 32 | MP0008469_abnormal_protein_level | 1.18461595 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.15172505 |
| 34 | MP0009785_altered_susceptibility_to | 1.10979912 |
| 35 | MP0001915_intracranial_hemorrhage | 1.08252820 |
| 36 | MP0000598_abnormal_liver_morphology | 1.06978908 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.04073655 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.02432807 |
| 39 | MP0009642_abnormal_blood_homeostasis | 1.01341952 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.01316504 |
| 41 | MP0003300_gastrointestinal_ulcer | 0.96675485 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96336453 |
| 43 | MP0010368_abnormal_lymphatic_system | 0.95129420 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 0.93763410 |
| 45 | MP0003879_abnormal_hair_cell | 0.91562731 |
| 46 | MP0001661_extended_life_span | 0.90732927 |
| 47 | MP0003724_increased_susceptibility_to | 0.90377670 |
| 48 | MP0003690_abnormal_glial_cell | 0.88646571 |
| 49 | MP0005164_abnormal_response_to | 0.87897946 |
| 50 | MP0002971_abnormal_brown_adipose | 0.86850315 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.85320097 |
| 52 | MP0009763_increased_sensitivity_to | 0.82571873 |
| 53 | MP0003075_altered_response_to | 0.82405064 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.82379192 |
| 55 | MP0005025_abnormal_response_to | 0.81885476 |
| 56 | MP0002419_abnormal_innate_immunity | 0.81773529 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.81680744 |
| 58 | MP0004883_abnormal_blood_vessel | 0.80279177 |
| 59 | MP0000685_abnormal_immune_system | 0.80017677 |
| 60 | MP0005083_abnormal_biliary_tract | 0.79165194 |
| 61 | MP0003303_peritoneal_inflammation | 0.77230054 |
| 62 | MP0000566_synostosis | 0.74248239 |
| 63 | MP0003011_delayed_dark_adaptation | 0.73418189 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 0.70645963 |
| 65 | MP0001845_abnormal_inflammatory_respons | 0.70535381 |
| 66 | MP0001756_abnormal_urination | 0.70493208 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.69663730 |
| 68 | MP0010155_abnormal_intestine_physiology | 0.69407320 |
| 69 | MP0009764_decreased_sensitivity_to | 0.69217476 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.68784949 |
| 71 | MP0006082_CNS_inflammation | 0.66953238 |
| 72 | MP0005166_decreased_susceptibility_to | 0.65530989 |
| 73 | MP0005448_abnormal_energy_balance | 0.64471796 |
| 74 | MP0005023_abnormal_wound_healing | 0.62749191 |
| 75 | MP0005409_darkened_coat_color | 0.61736119 |
| 76 | MP0002909_abnormal_adrenal_gland | 0.60347254 |
| 77 | MP0003329_amyloid_beta_deposits | 0.59985858 |
| 78 | MP0003123_paternal_imprinting | 0.58954038 |
| 79 | MP0000249_abnormal_blood_vessel | 0.58910675 |
| 80 | MP0002168_other_aberrant_phenotype | 0.58808232 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.56622896 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.55031524 |
| 83 | MP0006054_spinal_hemorrhage | 0.54898042 |
| 84 | MP0009115_abnormal_fat_cell | 0.54852724 |
| 85 | MP0000858_altered_metastatic_potential | 0.54609085 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.54559817 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.52867238 |
| 88 | MP0003953_abnormal_hormone_level | 0.51364633 |
| 89 | MP0001790_abnormal_immune_system | 0.50618437 |
| 90 | MP0005387_immune_system_phenotype | 0.50618437 |
| 91 | MP0003866_abnormal_defecation | 0.50389409 |
| 92 | MP0005395_other_phenotype | 0.49965116 |
| 93 | MP0000920_abnormal_myelination | 0.49605827 |
| 94 | MP0005334_abnormal_fat_pad | 0.48227865 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 0.47521045 |
| 96 | MP0005670_abnormal_white_adipose | 0.47148553 |
| 97 | MP0005535_abnormal_body_temperature | 0.46434898 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.46230070 |
| 99 | MP0002933_joint_inflammation | 0.44155926 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.43611283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.79721838 |
| 2 | Complement deficiency (HP:0004431) | 7.93177047 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 7.72626093 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.35719329 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.04974329 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.53589278 |
| 7 | Abnormality of complement system (HP:0005339) | 6.41358897 |
| 8 | Joint hemorrhage (HP:0005261) | 6.37465455 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.11104766 |
| 10 | Glomerulonephritis (HP:0000099) | 5.41813067 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 5.30688336 |
| 12 | Xanthomatosis (HP:0000991) | 5.14055555 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.55641930 |
| 14 | Spontaneous abortion (HP:0005268) | 4.44068077 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.38195676 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.20829701 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.02462259 |
| 18 | Gingival bleeding (HP:0000225) | 3.90350652 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.69277108 |
| 20 | Fat malabsorption (HP:0002630) | 3.64298076 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.58535608 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.58120049 |
| 23 | Hemorrhage of the eye (HP:0011885) | 3.52222261 |
| 24 | Nephritis (HP:0000123) | 3.41479141 |
| 25 | Purpura (HP:0000979) | 3.33328157 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.31208291 |
| 27 | Menorrhagia (HP:0000132) | 3.29590162 |
| 28 | Vascular calcification (HP:0004934) | 3.22478604 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.20204980 |
| 30 | Epidermoid cyst (HP:0200040) | 2.96317376 |
| 31 | Thrombophlebitis (HP:0004418) | 2.86078071 |
| 32 | Mitral stenosis (HP:0001718) | 2.81504055 |
| 33 | Cardiovascular calcification (HP:0011915) | 2.80372084 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76334158 |
| 35 | Steatorrhea (HP:0002570) | 2.74157410 |
| 36 | Acanthocytosis (HP:0001927) | 2.73821808 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.72387690 |
| 38 | Pulmonary embolism (HP:0002204) | 2.57321920 |
| 39 | Amyloidosis (HP:0011034) | 2.54426668 |
| 40 | Osteomalacia (HP:0002749) | 2.53787559 |
| 41 | Rickets (HP:0002748) | 2.53225181 |
| 42 | Hyperammonemia (HP:0001987) | 2.44317092 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.40080144 |
| 44 | Myocardial infarction (HP:0001658) | 2.36044901 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.34560718 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.34560718 |
| 47 | Arthropathy (HP:0003040) | 2.29923594 |
| 48 | Joint swelling (HP:0001386) | 2.27390069 |
| 49 | Hyperglycinemia (HP:0002154) | 2.24266344 |
| 50 | Epistaxis (HP:0000421) | 2.24104808 |
| 51 | Hypophosphatemic rickets (HP:0004912) | 2.17472901 |
| 52 | Orchitis (HP:0100796) | 2.16512809 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13793168 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.13793168 |
| 55 | Increased serum ferritin (HP:0003281) | 2.10829106 |
| 56 | Abnormal tarsal ossification (HP:0008369) | 2.09584493 |
| 57 | Facial shape deformation (HP:0011334) | 2.08922547 |
| 58 | Potter facies (HP:0002009) | 2.08922547 |
| 59 | Gangrene (HP:0100758) | 2.07646155 |
| 60 | Abnormality of iron homeostasis (HP:0011031) | 2.04665798 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.03225763 |
| 62 | Optic neuritis (HP:0100653) | 2.03225763 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.03185674 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.02039005 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.01631985 |
| 66 | Skin nodule (HP:0200036) | 1.96759657 |
| 67 | Mucopolysacchariduria (HP:0008155) | 1.93720390 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93720390 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93372551 |
| 70 | Hyperglycinuria (HP:0003108) | 1.93150436 |
| 71 | Widely patent fontanelles and sutures (HP:0004492) | 1.92541272 |
| 72 | Peritonitis (HP:0002586) | 1.89898404 |
| 73 | Glycosuria (HP:0003076) | 1.89650939 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 1.89650939 |
| 75 | Flat acetabular roof (HP:0003180) | 1.87175980 |
| 76 | Delayed CNS myelination (HP:0002188) | 1.86194239 |
| 77 | Myositis (HP:0100614) | 1.84847025 |
| 78 | Poikilocytosis (HP:0004447) | 1.84806480 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81998231 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81998231 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81998231 |
| 82 | Malnutrition (HP:0004395) | 1.79257158 |
| 83 | Abnormality of methionine metabolism (HP:0010901) | 1.79162489 |
| 84 | Hypochromic anemia (HP:0001931) | 1.77749787 |
| 85 | Cholecystitis (HP:0001082) | 1.77708910 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 1.77708910 |
| 87 | Enlarged kidneys (HP:0000105) | 1.72357002 |
| 88 | Abnormality of vitamin metabolism (HP:0100508) | 1.71529412 |
| 89 | Gout (HP:0001997) | 1.71047178 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 1.69518779 |
| 91 | Hyperphosphaturia (HP:0003109) | 1.69378069 |
| 92 | Hypoglycemic coma (HP:0001325) | 1.69321724 |
| 93 | Prolonged bleeding time (HP:0003010) | 1.69161937 |
| 94 | Hypophosphatemia (HP:0002148) | 1.69135333 |
| 95 | Hyperbilirubinemia (HP:0002904) | 1.67790380 |
| 96 | Pancreatitis (HP:0001733) | 1.66409655 |
| 97 | Proximal tubulopathy (HP:0000114) | 1.65825457 |
| 98 | Eczematoid dermatitis (HP:0000976) | 1.65557641 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64766067 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.63754720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 6.20916946 |
| 2 | ERN1 | 4.81261107 |
| 3 | FGFR3 | 3.92678909 |
| 4 | TYK2 | 2.68374541 |
| 5 | RIPK1 | 2.51366770 |
| 6 | ICK | 2.01798186 |
| 7 | TRIB3 | 1.83343759 |
| 8 | PIK3CA | 1.79413013 |
| 9 | MAP3K2 | 1.69403184 |
| 10 | FGFR2 | 1.65695901 |
| 11 | EPHB1 | 1.65297109 |
| 12 | ZAP70 | 1.60270967 |
| 13 | MAP3K3 | 1.60254153 |
| 14 | MAP2K3 | 1.53982715 |
| 15 | PDPK1 | 1.52033886 |
| 16 | EPHA3 | 1.51892131 |
| 17 | RIPK4 | 1.43885076 |
| 18 | MAPK11 | 1.38806542 |
| 19 | SIK1 | 1.38454842 |
| 20 | FGR | 1.36486572 |
| 21 | MAP3K1 | 1.33147430 |
| 22 | PRKAA2 | 1.30998512 |
| 23 | PKN2 | 1.29272246 |
| 24 | WNK4 | 1.29151670 |
| 25 | MAP4K1 | 1.23557960 |
| 26 | PDK1 | 1.23515770 |
| 27 | GRK6 | 1.22822385 |
| 28 | BLK | 1.21702332 |
| 29 | PTK6 | 1.21445601 |
| 30 | LMTK2 | 1.17812079 |
| 31 | TGFBR2 | 1.17558704 |
| 32 | CDK12 | 1.17185637 |
| 33 | KSR2 | 1.15592125 |
| 34 | DYRK1B | 1.14308502 |
| 35 | RET | 1.13514549 |
| 36 | CSK | 1.08475371 |
| 37 | IRAK3 | 1.06147753 |
| 38 | FGFR1 | 1.06035475 |
| 39 | PRKG2 | 1.05873848 |
| 40 | JAK1 | 1.05423111 |
| 41 | NLK | 1.04603202 |
| 42 | TAOK1 | 1.02779648 |
| 43 | PRPF4B | 0.99868658 |
| 44 | TBK1 | 0.99622175 |
| 45 | MST1R | 0.97696077 |
| 46 | TNK2 | 0.97385515 |
| 47 | IRAK4 | 0.95797092 |
| 48 | MAP3K11 | 0.94030920 |
| 49 | CSF1R | 0.92684099 |
| 50 | CDC42BPA | 0.92535735 |
| 51 | JAK2 | 0.92357892 |
| 52 | YES1 | 0.88518850 |
| 53 | PRKACG | 0.88254626 |
| 54 | MAP2K6 | 0.83964978 |
| 55 | STK24 | 0.82809959 |
| 56 | PIK3CG | 0.81471255 |
| 57 | PDGFRA | 0.81373620 |
| 58 | MAP3K6 | 0.81129528 |
| 59 | MATK | 0.81032630 |
| 60 | ERBB2 | 0.80466227 |
| 61 | MAP3K12 | 0.76425532 |
| 62 | WNK1 | 0.74824539 |
| 63 | TYRO3 | 0.74676695 |
| 64 | JAK3 | 0.74340146 |
| 65 | MAP3K14 | 0.71950865 |
| 66 | SIK2 | 0.69688023 |
| 67 | FER | 0.69399603 |
| 68 | ACVR1B | 0.68913245 |
| 69 | MAP2K4 | 0.68568660 |
| 70 | NTRK3 | 0.67035399 |
| 71 | SGK3 | 0.66859391 |
| 72 | AKT3 | 0.65144799 |
| 73 | PRKCZ | 0.64543807 |
| 74 | IRAK1 | 0.62087867 |
| 75 | SGK494 | 0.58935163 |
| 76 | SGK223 | 0.58935163 |
| 77 | MAP3K7 | 0.58265652 |
| 78 | LYN | 0.55655315 |
| 79 | LCK | 0.52960220 |
| 80 | SYK | 0.52831742 |
| 81 | SGK1 | 0.52482886 |
| 82 | IGF1R | 0.49052370 |
| 83 | IKBKE | 0.48714144 |
| 84 | NEK9 | 0.47713634 |
| 85 | MARK2 | 0.47341036 |
| 86 | EPHA2 | 0.47337210 |
| 87 | ITK | 0.46505135 |
| 88 | CDK6 | 0.46437283 |
| 89 | SRC | 0.45558096 |
| 90 | PDK2 | 0.45113606 |
| 91 | PRKAA1 | 0.43664012 |
| 92 | HCK | 0.43581212 |
| 93 | FYN | 0.43414505 |
| 94 | STK38 | 0.41828300 |
| 95 | MAP3K13 | 0.40781014 |
| 96 | CAMKK2 | 0.40480403 |
| 97 | SGK2 | 0.39877682 |
| 98 | FES | 0.39135518 |
| 99 | DAPK2 | 0.38954335 |
| 100 | MAP3K5 | 0.37795645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.80347740 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.57984901 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35227680 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28720198 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.90016133 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.81014999 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.79231210 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72875300 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.69739884 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.46209217 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.43130254 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37595300 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.31666222 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26295459 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.26136259 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.25909323 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25328714 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17574015 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.93959112 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.90956013 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.87933570 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.81482356 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77805200 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77774765 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72182930 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.65347833 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60099765 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57894759 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52934369 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39945136 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.27895960 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25517817 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23615527 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20290762 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18970055 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17402098 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.14697618 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13552455 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12571165 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10451799 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06692193 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00812246 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97295621 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96551762 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91496625 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.90731777 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90438573 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89877872 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84475602 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80558271 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.79326629 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78412756 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75837731 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75687953 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73935714 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71643248 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69156517 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69072484 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67272066 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63635270 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62114989 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59679004 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58654065 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58613013 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52172451 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.46192601 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44617926 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.43544609 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43209389 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39679166 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33903810 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33241763 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31564018 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.29299603 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27535129 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27211853 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26402048 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26161473 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23605695 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22962547 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22464787 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22311473 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20487236 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18133274 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12974638 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11757947 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.09799489 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.08137465 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.08026780 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07414047 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07366311 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01913225 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.01040178 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0744731 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0661127 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0509299 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0470337 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0344669 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0281355 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.0132004 |

